F. Brown

发表

Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients.

David W. Johnson, K. Sud, J. Craig, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Macrophage migration inhibitory factor expression in human renal allograft rejection.

R. Atkins, R. Bucala, C. Metz, 1998, Transplantation.

Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.

David W. Johnson, B. Piraino, J. Bernardini, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

David W. Johnson, A. Mallett, C. Hawley, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases

David W. Johnson, C. Hawley, Wen Tang, 2012, BMC Nephrology.

Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.

S. Mujais, Suhail Ahmad, A. Abu-Alfa, 2005, Journal of the American Society of Nephrology : JASN.

Challenges of conducting a trial of uric-acid-lowering therapy in CKD

David W. Johnson, V. Perkovic, G. Rangan, 2011, Nature Reviews Nephrology.

End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases.

David W. Johnson, C. Hawley, S. McDonald, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.

David W. Johnson, C. Hawley, S. McDonald, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of dialysis modality and cardiovascular mortality in incident dialysis patients.

David W. Johnson, C. Hawley, S. McDonald, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Predictors of Renal Recovery in Australian and New Zealand end-Stage Renal Failure Patients Treated with Peritoneal Dialysis

David W. Johnson, C. Hawley, S. McDonald, 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

David W. Johnson, C. Hawley, S. McDonald, 2010, Kidney international.

High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.

David W. Johnson, S. McDonald, J. Rosman, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of Allopurinol on the Progression of Chronic Kidney Disease.

David W. Johnson, R. Day, V. Perkovic, 2020, The New England journal of medicine.

Small solute clearance targets in peritoneal dialysis

David W. Johnson, R. Walker, F. Brown, 2005 .

Dialysis adequacy (PD) guidelines: Monitoring patients on peritoneal dialysis

David W. Johnson, R. Walker, F. Brown, 2005 .

The CARI guidelines. Dialysis adequacy (PD) guidelines.

David W. Johnson, R. Walker, F. Brown, 2005, Nephrology.

The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

David W. Johnson, M. Suranyi, Hemant Kulkarni, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients

M. Suranyi, N. Boudville, R. Langham, 2012 .

Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

David W. Johnson, C. Hawley, S. McDonald, 2012, Journal of the American Society of Nephrology : JASN.

Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.

David W. Johnson, C. Hawley, S. McDonald, 2010, Nephrology, Dialysis and Transplantation.

A Randomized Controlled Trial to Determine Whether Treatment with a Neutral pH, Low Glucose Degradation Product Dialysate (Balance) Prolongs Residual Renal Function in Peritoneal Dialysis Patients

F. Brown, D. Johnson, 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Optimizing small solute clearances in peritoneal dialysis

David W. Johnson, R. Walker, F. Brown, 2005 .

Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.

K. Polkinghorne, P. Kerr, A. Hurt, 2012, Kidney international.

Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.

David W. Johnson, M. Suranyi, Hemant Kulkarni, 2012, Journal of the American Society of Nephrology : JASN.

Representativeness of the PDOPPS cohort compared to the Australian PD population

David W. Johnson, P. Kerr, E. Milanzi, 2021, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action

David W. Johnson, K. Sud, M. Jose, 2016, Nephrology.

Microbiology and Outcomes of Peritonitis in Australian Peritoneal Dialysis Patients

David W. Johnson, S. McDonald, J. Ghali, 2011, Peritoneal Dialysis International.

The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: the balANZ Trial

David W. Johnson, M. Suranyi, Hemant Kulkarni, 2012, Peritoneal Dialysis International.

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis.

David W. Johnson, C. Hawley, S. McDonald, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study

David W. Johnson, C. Hawley, S. McDonald, 2012, BMC Nephrology.

Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.

David W. Johnson, C. Hawley, S. McDonald, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study.

David W. Johnson, C. Hawley, S. McDonald, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.

David W. Johnson, C. Hawley, S. McDonald, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.

David W. Johnson, C. Hawley, S. McDonald, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases.

David W. Johnson, C. Hawley, S. McDonald, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases.

David W. Johnson, C. Hawley, S. McDonald, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.

David W. Johnson, C. Hawley, S. McDonald, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Trials (and Tribulations) of Biocompatible Peritoneal Dialysis Fluids

David W. Johnson, F. Brown, Yeoungjee Cho, 2012, Peritoneal Dialysis International.

Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

David W. Johnson, F. Brown, Vanessa Wilson, 2010, BMC nephrology.

Socio-Economic Status and Peritonitis in Australian Non-Indigenous Peritoneal Dialysis Patients

David W. Johnson, C. Hawley, Wen Tang, 2015, Peritoneal Dialysis International.

Effects of Climatic Region on Peritonitis Risk, Microbiology, Treatment, and Outcomes: a Multicenter Registry Study

David W. Johnson, C. Hawley, S. McDonald, 2013, Peritoneal Dialysis International.

Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.

David W. Johnson, C. Hawley, S. McDonald, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

OP-NDTJ190156 2089..2126

B. Piraino, J. Bernardini, J. Perl, 2019 .

URINE MACROPHAGE MIGRATION INHIBITORY FACTOR CONCENTRATIONS AS A DIAGNOSTIC TOOL IN HUMAN RENAL ALLOGRAFT REJECTION1

R. Atkins, S. Chadban, R. Bucala, 2001, Transplantation.

PUBLISHED VERSION

K. Polkinghorne, D. Pisaniello, A. Hansen, 2015 .

Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.

P. Kerr, R. Carroll, F. Brown, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases

David W. Johnson, A. Mallett, C. Hawley, 2015, American Journal of Nephrology.

A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.

David W. Johnson, C. Hawley, N. Isbel, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dialysis and Transplant Registry

F. Brown, Katherine, M. Carmel, 2009 .

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease.

David W. Johnson, C. Hawley, Wen Tang, 2013, Kidney international.

A Quarter of a Century of Adult Peritoneal Dialysis-Related Peritonitis at an Australian Medical Center

R. Atkins, T. Korman, D. Kotsanas, 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Risk factors for peritoneal dialysis‐related peritonitis: Can we reduce the incidence and improve patient selection?

R. Atkins, K. Polkinghorne, T. Korman, 2007, Nephrology.

Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): the Australian cohort in a global aHUS registry.

G. Wong, P. T. Coates, W. Lim, 2020, Nephrology.

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.

David W. Johnson, C. Hawley, Wen Tang, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.

David W. Johnson, C. Hawley, S. McDonald, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.

R. Atkins, N. Isbel, D. Nikolic-Paterson, 2002, Journal of the American Society of Nephrology : JASN.

Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function.

David W. Johnson, C. Hawley, S. McDonald, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

N. Heyne, Y. Miyakawa, G. Ariceta, 2021, Kidney international reports.

Automated and continuous ambulatory peritoneal dialysis have similar outcomes.

C. Hawley, D. Johnson, S. McDonald, 2008, Kidney international.

Selection of patients for automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis

David W. Johnson, R. Walker, F. Brown, 2005 .

Compared with Younger Peritoneal Dialysis Patients, Elderly Patients Have Similar Peritonitis-Free Survival and Lower Risk of Technique Failure, But Higher Risk of Peritonitis-Related Mortality

David W. Johnson, S. McDonald, W. Lim, 2011, Peritoneal Dialysis International.

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.

David W. Johnson, C. Hawley, S. McDonald, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

David W. Johnson, C. Hawley, N. Isbel, 2009, BMC nephrology.

Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients.

David W. Johnson, C. Hawley, S. McDonald, 2009, Kidney international.

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.

David W. Johnson, V. Perkovic, D. Harris, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

5. Indications for the use of urokinase in peritoneal dialysis–associated peritonitis

J. Chow, C. George, K. Bannister, 2004 .

The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: indications for the use of urokinase in peritoneal dialysis-associated peritonitis.

J. Chow, C. George, K. Bannister, 2004, Nephrology.

Peritoneal Transport and Ultrafiltration

David W. Johnson, R. Walker, F. Brown, 2005 .

The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

David W. Johnson, C. Hawley, Wen Tang, 2013, Clinical journal of the American Society of Nephrology : CJASN.

3. Indications for recommencement of peritoneal dialysis after treatment for peritonitis

J. Chow, C. George, K. Bannister, 2004 .

Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab

F. Brown, S. Choo, 2017, Nephrology.

Patients' Perspectives on the Prevention and Treatment of Peritonitis in Peritoneal Dialysis: A Semi-Structured Interview Study

J. Craig, A. Tong, G. Wong, 2016, Peritoneal Dialysis International.

Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.

David W. Johnson, C. Hawley, S. McDonald, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases

David W. Johnson, C. Hawley, S. McDonald, 2009, BMC nephrology.

BK Virus Associated Nephropathy, a Cause of Early Renal Allograft Dysfunction: A Single Centre Study.

K. Polkinghorne, P. Kerr, J. Kanellis, 2017, Kathmandu University medical journal.

The Association between Body Mass Index and Mortality in Incident Dialysis Patients

David W. Johnson, K. Klein, K. Polkinghorne, 2014, PloS one.

Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.

David W. Johnson, K. Polkinghorne, C. Hawley, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

STAPHYLOCOCCUS AUREUS PERITONITIS IN AUSTRALIAN PERITONEAL DIALYSIS PATIENTS: PREDICTORS, TREATMENT, AND OUTCOMES IN 503 CASES

David W. Johnson, C. Hawley, S. McDonald, 2010, Peritoneal Dialysis International.

Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases.

David W. Johnson, C. Hawley, S. McDonald, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.

David W. Johnson, C. Hawley, S. McDonald, 2010, Kidney international.

Different faces of Nocardia infection in renal transplant recipients

K. Polkinghorne, P. Kerr, T. Korman, 2016, Nephrology.

PUBLISHED VERSION

K. Klein, K. Polkinghorne, S. Paul, 2014 .

Dialysis Adequacy (PD) Guidelines

R. Walker, F. Brown, Helen Lammi, 2005 .

Dialysis Adequacy (PD) guidelines: Selection of patients for automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis

R. Walker, F. Brown, Helen Lammi, 2005 .

Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.

K. Polkinghorne, P. Kerr, A. Hurt, 2012, Kidney international.